IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trials

IROC:增强 NCTN 试验的本地招募站点放射数据捕获能力

基本信息

  • 批准号:
    10544595
  • 负责人:
  • 金额:
    $ 39.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-26 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trials has Budget Details included in the extracted text as well as Personnel commitment time. We think this information should not be reported publicly. It looks like the Abstract appears on page 32 of the eIMG and starts with the sentence "With the evolution of increasingly complex therapeutic interventions in clinical trials as well as the utilization of advanced, more differentiated response assessment strategies, inconsistencies in the local response assessment are being noted when central reviews are performed within NCTN trials" and ends with the sentence, "We now intend to expand and refine these approaches to a national setting. While IROC Ohio will take the organizational lead, we will be working together with the four other IROC QA and support sites as well as the imaging committee of the NCTN groups." The start of the Specific Aims also appear on page 32 and start with the bolded title "A, Development of an in person as well as virtual workshop concept to train response assessors for NCTN clinical trials and ends with the sentence, "We are leveraging the basic IROC Ohio infrastructure both from the technical as well as staffing side to initiate and manage the project that will have active participation from all the other four QA and support sites."
IROC:增强NCTN试验的当地入组研究中心放射学数据采集能力的预算细节包括在摘录文本中以及人员承诺时间。我们认为这些信息不应该公开报道。看起来摘要出现在eIMG的第32页,以句子“随着临床试验中日益复杂的治疗干预的发展以及先进的、更差异化的缓解评估策略的利用,当在NCTN试验中进行中心审查时,注意到局部缓解评估的不一致性”开始,并以句子结束,“我们现在打算将这些方法扩大和完善到全国范围。虽然IROC俄亥俄州将担任组织领导,但我们将与其他四个IROC QA和支持中心以及NCTN组的成像委员会合作。“具体目标的开头也出现在第32页,以粗体标题“A,为NCTN临床试验培训反应评估员的亲自和虚拟研讨会概念的开发”开始,并以句子结束,"我们正在利用俄亥俄州IROC的基本基础设施,从技术和人员方面启动和管理项目,该项目将有所有的积极参与,其他四个QA和支持站点。"

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL V KNOPP其他文献

MICHAEL V KNOPP的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL V KNOPP', 18)}}的其他基金

Validating Low FDG Dose PET/CT compared to current Standard of Care Dose PET/CT
验证低 FDG 剂量 PET/CT 与当前护理标准剂量 PET/CT 的比较
  • 批准号:
    9086293
  • 财政年份:
    2015
  • 资助金额:
    $ 39.9万
  • 项目类别:
Imaging and Radiation Oncology Core (IROC) Group
影像和放射肿瘤学核心 (IROC) 小组
  • 批准号:
    9919498
  • 财政年份:
    2014
  • 资助金额:
    $ 39.9万
  • 项目类别:
Imaging and Radiation Oncology Core (IROC) Group
影像和放射肿瘤学核心 (IROC) 小组
  • 批准号:
    10582574
  • 财政年份:
    2014
  • 资助金额:
    $ 39.9万
  • 项目类别:
Imaging and Radiation Oncology Core (IROC) Group
影像和放射肿瘤学核心 (IROC) 小组
  • 批准号:
    10376892
  • 财政年份:
    2014
  • 资助金额:
    $ 39.9万
  • 项目类别:
Imaging and Radiation Oncology Core (IROC) Group
影像和放射肿瘤学核心 (IROC) 小组
  • 批准号:
    10117815
  • 财政年份:
    2014
  • 资助金额:
    $ 39.9万
  • 项目类别:
Imaging and Radiation Oncology Core (IROC) Group
影像和放射肿瘤学核心 (IROC) 小组
  • 批准号:
    10361187
  • 财政年份:
    2014
  • 资助金额:
    $ 39.9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了